论文部分内容阅读
目的：观察国产舒喘灵溶液和进口喘乐宁溶液雾化治疗疗效。方法：１６０例哮喘急性发作期患者，其中舒喘灵组８３例，喘乐宁组７７例，分别雾化吸入国产舒喘灵溶液和进口喘乐宁溶液２．５ｍｇ。结果：吸入国产舒喘灵溶液后ＦＥＶ１从５ｍｉｎ即显示增加，１ｈ左右达高峰（从（１．１６±０．４５）Ｌ升至（１．５５±０．５８）Ｌ，Ｐ＜０．０５），并可持续４ｈ。与进口喘乐宁溶液比较，两组患者在临床疗效、肺功能改善及副反应的发生率方面均无显著性差异。结论：舒喘灵溶液雾化吸入疗效确实，可用于支气管哮喘和其他可逆性气道阻塞患者的救治
Objective: To observe the effect of domestic salbutamol solution and imported salbutamol solution atomization therapy. Methods: One hundred and sixty patients with acute exacerbation of asthma were randomly divided into three groups: salbutamol group (n = 83) and salmeterin group (n = 77). Nebulized salbutamol solution and salmeterol 2.5mg were inhaled respectively. Results: FEV1 increased from 5 min after inhaling Chinese salbutamol solution and reached the peak at 1 h (from (1.16 ± 0.45) L to (1.55 ± 0.58) L, P <0.05 ), And sustainable 4h. Compared with the imported salbutamol solution, the two groups of patients in the clinical efficacy, improvement of lung function and the incidence of side effects no significant difference. Conclusion: Salbutamol solution atomization inhalation effect is indeed useful in patients with bronchial asthma and other reversible airway obstruction